Journal for ImmunoTherapy of Cancer (Nov 2020)
149 GEN-011: An ATLASTM-guided peripheral-blood derived neoantigen-specific T cell therapy designed to improve on TIL approaches
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2020)